Edison Open House: Global Healthcare 2021 and will discuss the pivotal GBM AGILE study and the key upcoming milestones for Kazia in 2021.
Dr James Garner mentions:-
1 Patient alive more than 2 years after diagnosis with the phase 2 GBM trial.
The paxalisib recruitment arm commenced several weeks ago for the GBM AGILE study.
Potentially best in class toxicity for PI3K pathway.
During 2021 Kazia will focus on commercialization.
https://www.lsegissuerservices.com/spark/Kazia/events/4b08bd3c-338a-4a2e-b5c6-d5b0a94b5ea9
Regards
- Forums
- ASX - By Stock
- KZA
- KZA Media Thread
KZA Media Thread, page-1289
-
- There are more pages in this discussion • 778 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online